All Search Results
News Releases
Sep 20, 2026, 08:23 ET S2S China Announces 2026 Finalists, Ten Standout Teams Set to Pitch Global Investors at Westlake University
dedicated to pursuing scientific breakthroughs that improve people's lives. The company focuses on immunology, oncology, neurology, rare diseases, ophthalmology and vaccines, and maintains a significant R&D and commercial presence in China, where it has long invested in partnerships with local academic
More news about: Qiming Venture Partners
Sep 20, 2026, 08:18 ET S2S China Announces 2026 Finalists, Ten Standout Teams Set to Pitch Global Investors at Westlake University
dedicated to pursuing scientific breakthroughs that improve people's lives. The company focuses on immunology, oncology, neurology, rare diseases, ophthalmology and vaccines, and maintains a significant R&D and commercial presence in China, where it has long invested in partnerships with local academic
More news about: Qiming Venture Partners
Sep 17, 2026, 09:00 ET ZEISS expands retinal imaging portfolio with new ZEISS ALTA DUO 300
fully automated, multimodal device to the ZEISS OCT portfolio, complementing the comprehensive CIRRUS solution," says Andreas Völker, Head of the Ophthalmology Strategic Business Unit, ZEISS Medical Technology."Many practices are looking for ways to integrate retinal imaging into everyday patient
More news about: Carl Zeiss Meditec AG
Sep 17, 2026, 09:00 ET ZEISS expands retinal imaging portfolio with new ZEISS ALTA DUO 300
fully automated, multimodal device to the ZEISS OCT portfolio, complementing the comprehensive CIRRUS solution," says Andreas Völker, Head of the Ophthalmology Strategic Business Unit, ZEISS Medical Technology."Many practices are looking for ways to integrate retinal imaging into everyday patient
More news about: Carl Zeiss Meditec AG
Sep 17, 2026, 08:30 ET Sun Pharma and Christian Siriano Launch "Regrowth Restyled" to Inspire Adults Living with Severe Alopecia Areata
in the US as well as Global Emerging Markets. Sun's high growth Global Innovative Medicines portfolio spans innovative products in dermatology, ophthalmology, and oncodermatology and accounts for about 22% of company sales. The company's vertically integrated operations deliver high-quality medicines,
More news about: Sun Pharma
